Literature DB >> 34826742

Clinicopathological features and genomic profiles of hepatoid adenocarcinoma of the lung: Report of four cases.

Hui Sun1, Xiaoli Li1, Jianguo Zhang2, Yifei Liu3.   

Abstract

OBJECTIVE: Pathological features of hepatoid adenocarcinoma of the lung (HAL) are similar to those of hepatocellular carcinoma (HCC) and HAL has a poor prognosis. In this study, we aimed to elucidate clinicopathologic and molecular features of HAL.
METHODS: Four cases of HAL patients with one lobe of the lung resected were enrolled into the study. Next generation sequencing (NGS) of a 425-gene panel was performed on tumor tissue samples.
RESULTS: The most frequently mutated gene was TP53 in three cases of primary HAL and one case of metastatic HAL, with a mutation rate of 100%. Also, CDK8, CDKN2A, EPHA5, SMARCA4, and STK11 were detected as high-frequency mutations, with a mutation rate of 50%. The types of TP53 mutation included two missense variants and two frameshift ones. The TP53 mutation was related to the occurrence of HAL.
CONCLUSION: HAL could be caused by genetic mutations and is closely related to TP53 mutation.
Copyright © 2021 The Authors. Published by Elsevier GmbH.. All rights reserved.

Entities:  

Keywords:  Hepatoid adenocarcinoma of the lung; Immunotherapy; NGS; PD1 and PD-L1; TP53 mutation

Mesh:

Year:  2021        PMID: 34826742     DOI: 10.1016/j.prp.2021.153652

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  3 in total

1.  Primary Hepatoid Adenocarcinoma of the Lung: A Systematic Literature Review.

Authors:  Zhitao Chen; Chenchen Ding; Ting Zhang; Yahui He; Guoping Jiang
Journal:  Onco Targets Ther       Date:  2022-06-01       Impact factor: 4.345

2.  Hepatoid Adenocarcinoma of the Lung: Beyond a Shadow of Doubt and Risk of High Mortality [Letter].

Authors:  Syeda Sakina Zehra; Zoha Jahangir; Aleena Batool
Journal:  Onco Targets Ther       Date:  2022-08-02       Impact factor: 4.345

3.  Whole-exome sequencing and bioinformatics analysis of a case of non-alpha-fetoprotein-elevated lung hepatoid adenocarcinoma.

Authors:  Yao Yao; Xiaojiao Guan; Guangyao Bao; Jie Liang; Tian Li; Xinwen Zhong
Journal:  Front Pharmacol       Date:  2022-08-26       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.